Defective β-Adrenergic Receptor Signaling Precedes the Development of Dilated Cardiomyopathy in Transgenic Mice with Calsequestrin Overexpression
Open Access
- 1 August 1999
- journal article
- Published by Elsevier
- Vol. 274 (32) , 22251-22256
- https://doi.org/10.1074/jbc.274.32.22251
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted miceProceedings of the National Academy of Sciences, 1998
- Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart.Journal of Clinical Investigation, 1998
- Targeting the Receptor-G q Interface to Inhibit in Vivo Pressure Overload Myocardial HypertrophyScience, 1998
- Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin.Journal of Clinical Investigation, 1998
- Sarcoplasmic reticulum in heart failure: central player or bystander?Cardiovascular Research, 1998
- Mechanism of β-Adrenergic Receptor Desensitization in Cardiac Hypertrophy Is Increased β-Adrenergic Receptor KinaseJournal of Biological Chemistry, 1997
- Defective Excitation-Contraction Coupling in Experimental Cardiac Hypertrophy and Heart FailureScience, 1997
- Cardiac Function in Mice Overexpressing the β-Adrenergic Receptor Kinase or a βARK InhibitorScience, 1995
- Transcriptional Regulation During Cardiac Growth and DevelopmentAnnual Review of Physiology, 1993
- Wall stress and patterns of hypertrophy in the human left ventricle.Journal of Clinical Investigation, 1975